Cargando…

Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective study

BACKGROUND: Synergistic antitumor effects of immunotherapy and chemotherapy have been demonstrated in several solid tumors. However, this combination strategy has not been addressed in gestational trophoblastic neoplasia (GTN) cases. We therefore compared the safety and therapeutic effect of anti-pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaoyu, Cang, Wei, Liu, Xiaomei, Cheng, Yu, Wan, Xirun, Feng, Fengzhi, Ren, Tong, Zhao, Jun, Jiang, Fang, Cheng, Hongyan, Gu, Yu, Chen, Lihua, Li, Chen, Li, Xiuqin, Yang, Junjun, Lu, Xin, Xiang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154962/ https://www.ncbi.nlm.nih.gov/pubmed/37152364 http://dx.doi.org/10.1016/j.eclinm.2023.101974

Ejemplares similares

Gestational Trophoblastic Neoplasia With Urinary System Metastasis: A Single Center Experience
por: Cheng, Hongyan, et al.
Publicado: (2020)

Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia
por: Xue, Wei, et al.
Publicado: (2023)

Expression of the immune targets in tumor-infiltrating immunocytes of gestational trophoblastic neoplasia
por: Cheng, Hongyan, et al.
Publicado: (2023)

Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017
por: Kong, Yujia, et al.
Publicado: (2020)

Pulmonary resection of residual lesions of pulmonary metastasis from gestational trophoblastic neoplasia
por: Wang, Weidi, et al.
Publicado: (2023)

Identification and treatment of primary cervical gestational trophoblastic neoplasia: a retrospective study of 13 patients and literature review
por: Wang, Xiaoyu, et al.
Publicado: (2021)

Fertility-sparing uterine lesion resection for young women with gestational trophoblastic neoplasias: single institution experience
por: Wang, Xiaoyu, et al.
Publicado: (2017)

Anti-Müllerian hormone levels in patients with gestational trophoblastic neoplasia treated with different chemotherapy regimens: a prospective cohort study
por: Bi, Xiaoning, et al.
Publicado: (2017)

Management and prognosis of patients with liver metastases from gestational trophoblastic neoplasia: a retrospective cohort study
por: Zong, Liju, et al.
Publicado: (2018)

Management and Predictors of Treatment Failure in Patients with Chemo-Resistant/Relapsed Gestational Trophoblastic Neoplasia with Lung Metastasis
por: Kong, Yujia, et al.
Publicado: (2022)

Effectiveness of craniotomy and long-term survival in 35 patients with gestational trophoblastic neoplasia with brain metastases: a clinical retrospective analysis
por: Li, Yuan, et al.
Publicado: (2022)

Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia
por: Li, Lei, et al.
Publicado: (2018)

Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia: a 24-year experience in Peking union medical college hospital
por: Xiao, Changji, et al.
Publicado: (2015)

Epithelioid Trophoblastic Tumors: Treatments, Outcomes, and Potential Therapeutic Targets
por: Yang, Junjun, et al.
Publicado: (2019)

The anti-PD-1 era of cervical cancer: achievement, opportunity, and challenge
por: Li, Chen, et al.
Publicado: (2023)

Diagnosis and Management of Mixed Gestational Trophoblastic Neoplasia: A Study of 16 Cases and a Review of the Literature
por: Kong, Yujia, et al.
Publicado: (2019)

Thoracotomy in refractory gestational trophoblastic neoplasia with lung metastasis after normalization of serum beta human chorionic gonadotropin (β-hCG) with salvage chemotherapy
por: Feng, Fengzhi, et al.
Publicado: (2014)

Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone
por: Afzal, Muhammad Zubair, et al.
Publicado: (2018)

Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer
por: Que, Yi, et al.
Publicado: (2021)

Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
por: Long, Yiru, et al.
Publicado: (2022)

Progresses and Perspectives of Anti-PD-1/PD-L1 Antibody Therapy in Head and Neck Cancers
por: Yang, Bo, et al.
Publicado: (2018)

The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy
por: Tunger, Antje, et al.
Publicado: (2019)

Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy
por: Peng, Ye, et al.
Publicado: (2021)

Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia
por: Hart, Christina, et al.
Publicado: (2015)

Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies
por: Boustani, Jihane, et al.
Publicado: (2021)

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
por: Niu, Mengke, et al.
Publicado: (2021)

Microbiota and Extracellular Vesicles in Anti-PD-1/PD-L1 Therapy
por: Mishra, Surbhi, et al.
Publicado: (2022)

Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
por: Chen, Jiming, et al.
Publicado: (2022)

Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis
por: Liu, Haoran, et al.
Publicado: (2020)

Wong-type dermatomyositis during anti–PD-1 therapy
por: Yu, Wesley Y., et al.
Publicado: (2018)

Isolated epithelioid trophoblastic tumor of the vagina: a case report and review of the literature
por: Zhao, Jing, et al.
Publicado: (2013)

Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer
por: de Jong, Florus C., et al.
Publicado: (2021)

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
por: Bhave, Prachi, et al.
Publicado: (2022)

Role of CXCR3 signaling in response to anti-PD-1 therapy
por: Han, Xiao, et al.
Publicado: (2019)

Anti-PD-1 Therapy-Associated Perforating Colitis
por: Celli, Romulo, et al.
Publicado: (2018)

Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study
por: Chen, San-Chi, et al.
Publicado: (2022)

Vascular Thrombosis and Anti-PD-1 Therapy: A Series of Cases
por: Fu, Changfang, et al.
Publicado: (2021)

Role of surgical therapy in the management of gestational trophoblastic neoplasia
por: Eoh, Kyung Jin, et al.
Publicado: (2015)

Clinical Management of Pneumonitis in Patients Receiving Anti–PD-1/PD-L1 Therapy
por: Bala-Hampton, Justin E., et al.
Publicado: (2018)

Prospects of the potential strategies to improve the efficacy of anti‐PD‐1/PD‐L1 therapy
por: Yamaguchi, Hirohito, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l9uks5l9cf9dl57j1obhi7tp7k